47. Drug Dosing: One Size Does Not Fit All
![The Accad & Koka Report](https://cdn.mises.org/styles/responsive_4_3_650w/s3/static-page/img/AccadKokaReport_750x516.png.webp?itok=gYD67U7P 650w,https://cdn.mises.org/styles/responsive_4_3_870w/s3/static-page/img/AccadKokaReport_750x516.png.webp?itok=--wemeiE 870w,https://cdn.mises.org/styles/responsive_4_3_1090w/s3/static-page/img/AccadKokaReport_750x516.png.webp?itok=BzITQwvF 1090w,https://cdn.mises.org/styles/responsive_4_3_1310w/s3/static-page/img/AccadKokaReport_750x516.png.webp?itok=POcg_ea6 1310w,https://cdn.mises.org/styles/responsive_4_3_1530w/s3/static-page/img/AccadKokaReport_750x516.png.webp?itok=bWiGOSdm 1530w)
Patients come in all sizes and shapes, and with varying tolerance for complications and risk. Is it plausible that a single dosing regimen can optimize treatment for everybody? If not, what is keeping the pharmaceutical industry from endorsing a more dynamic and patient-centered drug dosing regimen?
Our guest is Dr. David Norris, a physician, mathematician, and inventor. David operates a scientific and statistical consultancy focused on methodology development for precision-medicine applications. He developed Dose Titration Algorithm Tuning (DTAT), a methodological framework that conceives dose individualization as a seamless learning process, beginning in early-phase trials and continuing throughout the drug development process. Before earning his M.D. at Brown University, he worked in diverse application areas including mathematical finance, operations research and systems engineering.
The Accad and Koka Report podcast, hosted by two MDs, focuses on free-market approaches to medicine and health. Subscribe on iTunes, Android, Stitcher, or via RSS.